Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FYBHG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Xtandi 40 mg tablets (120-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge location with an ultimate completion date of September 10, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete on equal footing in the federal marketplace.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026, which authorizes the agency to place firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group maintains an established portfolio delivering branded and generic prescription medications, biologics, and medical consumables to military and federal healthcare systems. Xtandi, an oncology treatment, represents one of the specialized pharmaceutical products within the vendor's scope of supply to support DoD medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FYBHG?
SPE2DB25FYBHG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FYBHG worth?
The government has obligated $4,170 on SPE2DB25FYBHG.
Is contract SPE2DB25FYBHG an order under another contract?
Yes. SPE2DB25FYBHG is a delivery order under SPE2DB24D9313, an indefinite delivery contract.
Was contract SPE2DB25FYBHG competed?
The extent of competition for SPE2DB25FYBHG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award